Company: ECIA
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001079973-25-001132
Chunk: 0

Company: ENCISION INC
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1
Chunk 0
---
Company
Overview

Encision Inc. (“Encision”, “we”,
“us”, “our” or the “Company"), a medical device company based in Boulder, Colorado, has developed and
markets innovative technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. We believe that our
patented Active Electrode Monitoring (AEM®) Surgical Instruments are changing the marketplace for electrosurgical devices and laparoscopic
instruments by providing a solution to a well-documented hazard unique to laparoscopic surgery.

We address market opportunities created by the
increase in minimally invasive surgery (“MIS”) and surgeons’ use of electrosurgery devices in these procedures. The
product opportunity exists in that monopolar electrosurgery instruments used in laparoscopic procedures provide excellent clinical results
but are also susceptible to causing inadvertent collateral tissue damage outside the surgeon’s field of view. The risk of unintended
electrosurgical burn injury to the patient in laparoscopic surgery has been well documented. This risk threatens patient safety, including
the risk of death, and creates liability exposure for surgeons and hospitals, and increases preventable readmissions. Our technology helps
to reduce hospital risk and liability.

Our patented AEM technology provides surgeons
with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy
that can cause complications and even death. AEM Surgical Instruments are equivalent to conventional instruments in size, shape, ergonomics,
and functionality, but they incorporate a proprietary shield and electrically connect to an Active Electrode Monitor to dynamically and
continuously monitor the flow of electrosurgical current, thereby preventing patient injury from stray monopolar energy. With our “shielded
and monitored” instruments, surgeons are able to perform electrosurgical procedures more safely, effectively, and economically than
is possible using conventional instruments.

AEM technology has been recommended and endorsed
by sources from many groups involved in MIS. Surgeons, nurses, biomedical engineers, the medicolegal community, malpractice insurance
carriers, and electrosurgical device manufacturers advocate the use of AEM technology. In May 2020, the Food and Drug Administration issued
a Safety Communication that stated, "In addition to serving as an ignition source, monopolar energy use can directly result in unintended
patient burns from capacitive coupling and intra-operative insulation failure.”

Business
Highlights

Proprietary, Patented Technology

We have developed and launched patented AEM Surgical